Connor, Clark & Lunn Investment Management (CC&L)’s Replimune Group REPL Stock Holding History
Bought
Maintained
Sold
Other funds holding REPL
BBA
RI
SCM
FIS
VCM
Connor, Clark & Lunn Investment Management (CC&L)'s REPL Position: Q1 2026 in Review
Connor, Clark & Lunn Investment Management (CC&L) opened a new position in Replimune Group (REPL) in Q1 2026: 86,910 shares worth $665K. The stake represents ﹤0.01% of the portfolio and ranks #1252 among its holdings. This is a return to the name: Connor, Clark & Lunn Investment Management (CC&L) previously reported a position in REPL as recently as Q4 2024.
Connor, Clark & Lunn Investment Management (CC&L) first reported a position in REPL in Q2 2022 and has held it in 12 quarters since. The position peaked at $2.08M in Q2 2023. 180 funds tracked by Wall St. Rank hold REPL as of Q1 2026.
- Connor, Clark & Lunn Investment Management (CC&L) held 86,910 shares of Replimune Group worth $665K as of Q1 2026.
- Replimune Group was a new Connor, Clark & Lunn Investment Management (CC&L) position in Q1 2026.
- Replimune Group made up ﹤0.01% of Connor, Clark & Lunn Investment Management (CC&L)'s portfolio in Q1 2026, its #1252 holding.
- Connor, Clark & Lunn Investment Management (CC&L) first reported a position in Replimune Group in Q2 2022 and has held it in 12 quarters since.
- Connor, Clark & Lunn Investment Management (CC&L)'s Replimune Group position peaked at $2.08M in Q2 2023.
- 180 funds tracked by Wall St. Rank held Replimune Group as of Q1 2026.
Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q1 2026, filed 11 May 2026.